Elevated Blood Pressure Clinical Trial
Official title:
Efficacy of Mental and Physical Training on Blood Pressure and Resting Heart Rate Among Physically Inactive Young Adults With Elevated and High Blood Pressure
Verified date | January 2023 |
Source | Universiti Tunku Abdul Rahman |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Elevated blood pressure or prehypertension is highly associated with increased risk of developing hypertension, cardiovascular event, and type II diabetes. Many physically inactive young adults, particularly in Malaysia have blood pressure higher than normal range, therefore it is important to control the blood pressure within normal range as prophylactic measure. This experimental research will be carried out to study the effect of physical training (aerobic exercise) and mental training (mindfulness meditation) with diet as a control group on the systolic blood pressure, diastolic blood pressure and resting heart rate among young adult with elevated blood pressure living a sedentary lifestyle. Participant will be divided into 2 experimental groups (mental and physical training) and 1 control group (Dietary Approaches to Stop Hypertension -DASH diet plan) who need to complete the prescribed intervention for 6 weeks. Results will be analysed by repeated measures ANOVA followed by post-hic test.
Status | Completed |
Enrollment | 62 |
Est. completion date | January 19, 2023 |
Est. primary completion date | January 18, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 25 Years |
Eligibility | Inclusion Criteria: - Male adults aged 18-25 years - Normal BMI (18.5-24.9) - Physically inactive - SBP between 120-139 mmHg and/or DBP between 60-89 mmHg - No hearing abnormalities - Willing to participate Exclusion Criteria: - Participants who have cardiovascular, musculoskeletal, and neurological disorders or any other medical condition that would restrict them to participate in the exercise - Those who are taking antihypertensive medications or other medications that will affect their BP and heart rate - Participants who are currently engaging in any form of relaxation techniques such as yoga or meditation - Individuals who are actively engaged in physical activities |
Country | Name | City | State |
---|---|---|---|
Malaysia | Universiti Tunku Abdul Rahman | Kajang | Selangor |
Lead Sponsor | Collaborator |
---|---|
Universiti Tunku Abdul Rahman |
Malaysia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline Systolic Blood Pressure at 6 weeks. | Systolic blood pressure (SPB) will be measured at baseline (before intervention begin), after 3 weeks of intervention, and post 6-weeks of intervention. | At baseline over a period of 6 weeks. | |
Primary | Change from Baseline Diastolic Blood Pressure at 6 weeks. | Diastolic blood pressure (DPB) will be measured at baseline (before intervention begin), after 3 weeks of intervention, and post 6-weeks of intervention. | At baseline over a period of 6 weeks. | |
Primary | Change from Baseline Mean Arterial Pressure at 6 weeks. | Mean arterial pressure (MAP) will be measured at baseline (before intervention begin), after 3 weeks of intervention, and post 6-weeks of intervention. | At baseline over a period of 6 weeks. | |
Primary | Change from Baseline Resting Heart Rate at 6 weeks. | Resting heart rate (RHR) will be measured at baseline (before intervention begin), after 3 weeks of intervention, and post 6-weeks of intervention. | At baseline over a period of 6 weeks. | |
Primary | Change from Baseline Pulse Pressure at 6 weeks. | Pulse pressure will be measured at baseline (before intervention begin), after 3 weeks of intervention, and post 6-weeks of intervention. | At baseline over a period of 6 weeks. | |
Secondary | Change from Baseline Body Mass Index at 6 weeks. | Body mass index (BMI) will be measured at baseline (before intervention begin), after 3 weeks of intervention, and post 6-weeks of intervention. | At baseline over a period of 6 weeks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03626363 -
Mindfulness and Neural Cardiovascular Control in Humans
|
N/A | |
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT04953650 -
Intermittent Fasting Towards Elevated Blood Pressure
|
N/A | |
Enrolling by invitation |
NCT06033417 -
Walking and Blood Pressure in Older Adults With Respiratory Impairment.
|
N/A | |
Completed |
NCT03716960 -
The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.
|
N/A | |
Completed |
NCT05029427 -
Effect of Oat Beta Glucan in Managing Blood Pressure
|
N/A | |
Recruiting |
NCT05370625 -
To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
|
N/A | |
Not yet recruiting |
NCT06376812 -
No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women
|
N/A | |
Not yet recruiting |
NCT06348225 -
Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure
|
N/A | |
Active, not recruiting |
NCT04766424 -
Sleep Technology Intervention to Target Cardiometabolic Health
|
N/A | |
Recruiting |
NCT05297708 -
Office, Home, and Ambulatory Blood Pressure
|
||
Completed |
NCT00869193 -
Effect of Grape Seed Extract on Blood Pressure
|
N/A | |
Completed |
NCT04298944 -
Association of Mood With Risk for Atherosclerosis
|
||
Recruiting |
NCT05397535 -
Baduanjin Lower Elevated Blood PreSsure Study
|
N/A | |
Completed |
NCT05928676 -
Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure
|
N/A | |
Not yet recruiting |
NCT03764020 -
Trial of Oral Melatonin in Elevated Blood Pressure
|
Phase 3 | |
Suspended |
NCT03508739 -
Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
|
Phase 3 | |
Active, not recruiting |
NCT05469503 -
Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
|
N/A | |
Recruiting |
NCT05955040 -
Treatment of Elevated Blood Pressures in Early Pregnancy
|
Phase 2 |